Page last updated: 2024-10-31

midodrine and Breast Neoplasms

midodrine has been researched along with Breast Neoplasms in 1 studies

Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.

Breast Neoplasms: Tumors or cancer of the human BREAST.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fairman, KA1
Curtiss, FR1

Other Studies

1 other study available for midodrine and Breast Neoplasms

ArticleYear
Regulatory actions on the off-label use of prescription drugs: ongoing controversy and contradiction in 2009 and 2010.
    Journal of managed care pharmacy : JMCP, 2010, Volume: 16, Issue:8

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antipsychotic Agen

2010